
    
      Patients with anterior Q-wave MIs and ejection fractions<=40% will be enrolled within the
      first 4 days of infarction. Patients will be randomized to receive either enoxaparin 1mg/kg
      (maximum 100mg) subcutaneously every 12 hours for one month or heparin followed by oral
      warfarin for 3 months.

      Clinical and safety evaluations, 2-D echocardiograms at baseline and at 3.5 months and cost
      analysis will be performed.
    
  